jRCT2033210163进行中（未招募）不适用
A phase I/II study of human induced Pluripotent Stem (iPS) cell-derived cardiomyocyte spheroids in patients with severe heart failure, secondary to ischemic heart disease, undergoing coronary artery bypass grafting (LAPiS Study)
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 10
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
- 干预模型
- Single Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 20age old over 至 80age old under（—）
- 性别
- All
入选标准
- •Patients with ischemic heart disease undergoing CABG
- •Patients with resting left ventricular ejection fraction (from 0.15 to 0.40) based on institutional assessment on either screening cardiac MRI or echocardiographic assessment
- •New York Heart Association Class II, III or IV
排除标准
- •Patients who are candidates for cardiovascular surgery other than CABG (such as valvular heart surgery)
- •Patients with the following complications
- •Pulmonary hypertension, hypertension, diabetes, liver dysfunction, liver dysfunction, gait disturbance, active infection, active bleeding
结局指标
主要结局
-
Safety
次要结局
未报告次要终点
研究者
相似试验
招募中
1 期
A phase I/II study of human induced Pluripotent Stem (iPS) cell-derived cardiomyocyte spheroids in patients with severe heart failure, secondary to ischemic heart disease, undergoing coronary artery bypass graftingHeart failure with ischemic heart diseaseIschemic heart disease, Heart Failure, Coronary artery bypass grafting (CABG)JPRN-jRCT2033210163Kaneko Takehiko10
招募中
不适用
Follow-up study of human induced Pluripotent Stem (iPS) cell-derived cardiomyocyte spheroids in patients with severe heart failure, secondary to ischemic heart disease, undergoing coronary artery bypass graftingjRCT2033240156Heartseed Inc10
已完成
1 期
Clinical trial of human (allogeneic) induced pluripotent stem cell-derived cardiomyocyte sheet for severe cardiomyopathyIschemic cardiomyopathyJPRN-UMIN000032989Osaka University3
招募中
不适用
Establishment and analyses of induced pluripotent stem (iPS) cells / human-induced neuronal (hiN) cells / induced microglia-like (iMG) cells from tissue, to elucidate the pathogenesis and pathophysiology of mental and developmental disorders.Multifactorial psychiatric disorders including schizophrenia, depression, bipolar disorders, neurocognitive disorders, eating disorders, anxiety disorders, sleep disorders and autism spectrum disordersJPRN-UMIN000020468Department of Psychiatry, Nagoya University, Graduate School of Medicine30
进行中（未招募）
不适用
Phase I, Two-Part, Multi-Center, First-in-Human Study of DS-6000a in Subjects with Advanced Renal Cell Carcinoma and Ovarian TumorsjRCT2031220075DAIICHI SANKYO Co.,Ltd.180